Clinical Imaging 2004-01-01

Confluent hepatic fibrosis as the presenting imaging sign in nonadvanced alcoholic cirrhosis.

Nikolaos L Kelekis, Eirini Makri, Aikaterini Vassiou, Kalliopi Patsiaoura, Michalis Spiridakis, Georgios N Dalekos

Index: Clin. Imaging 28(2) , 124-7, (2004)

Full Text: HTML

Abstract

Confluent hepatic fibrosis (CHF) is usually a feature of advanced cirrhosis, while occurrence in early stage compensated cirrhosis is uncommon. We report the imaging findings of masslike CHF in a patient with previously unsuspected compensated alcoholic cirrhosis. The combination of partially wedge shape, minimal capsular retraction, and homogeneous delayed enhancement on multiphase contrast-enhanced spiral CT led to the characterization of the lesions and establishment of the diagnosis of cirrhosis.

Related Compounds

  • Iopentol

Related Articles:

Value of single-dose contrast-enhanced magnetic resonance angiography versus intraarterial digital subtraction angiography in therapy indications in abdominal and iliac arteries.

2007-01-01

[Cardiovasc. Intervent. Radiol. 30(3) , 376-82, (2007)]

[Determination of the distribution volume of contrast media solutions injected intrahepatically: pre-pilot studies for intratumoral gene therapy].

2002-03-01

[Rofo. 174(3) , 357-62, (2002)]

Influence of two non-ionic radiographic contrast media with different osmolalities on coagulation in invasive cardiology. A prospective, randomised comparative study.

2002-11-01

[Acta radiol. 43(6) , 617-22, (2002)]

Low-high and high-low biphasic injection forms in computed tomography examinations of the upper abdomen.

2006-02-01

[Acta radiol. 47(1) , 10-4, (2006)]

Cerebral CT angiography using a small volume of concentrated contrast material with a test injection method: optimal scan delay for quantitative and qualitative performance.

2012-09-01

[Br. J. Radiol. 85(1017) , e748-55, (2012)]

More Articles...